Exclusif
Release Date
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.
NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.
NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.
NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine.
NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.